SCHEMBL1895685

SCHEMBL1895685

CCC(F)(F)C(=O)OF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9618300 0.81 CES2 (0.32)
SCHEMBL11630550 0.81 ALDH1A1 (0.33)
SCHEMBL1583583 0.79
SCHEMBL16139838 0.78 CES2 (0.54)
SCHEMBL1144196 0.77
SCHEMBL28429573 0.77 CES2 (0.30)
SCHEMBL1681615 0.77 CYP4F2 (0.44)
SCHEMBL1097334 0.77
SCHEMBL2880832 0.77 CES2 (0.53)
SCHEMBL6350851 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021240331-A1 PROCESS FOR THE PREPARATION OF 3,5-DICHLORO-2,2,2-TRIFLUOROACETOPHENONE HIKAL LIMITED (IN) 2021-12-02 WO claimed
CN-109790121-A It is used to prepare the method and intermediate of BTK inhibitor 詹森药业有限公司 2019-05-21 CN claimed
WO-2015118515-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR DISCOVERY INTERMEDIATES PRIVATE LIMITED (IN) 2015-08-13 WO claimed
WO-2013186792-A2 PROCESS FOR THE PREPARATION OF (5-METHYL-2-OXO-L,3-DIOXOI-4-VL)METHVL 2- ETHOXV-L-{[2'-(5-OXO-4,5-DIHVDRO-L,2,4-OXADIAZOL-3-VL)BIPHENYI-4-VL]METHYL}- LH-BENZIMIDAZOLE-7-CARBOXYIATE AND ITS SALTS MSN LABORATORIES LIMITED (IN) 2013-12-19 WO claimed
CN-117384010-A Continuous preparation method of 2, 2-trifluoroethanol 浙江巨化技术中心有限公司 2024-01-12 CN disclosed
CN-115636723-B Preparation method of trifluoroethanol 浙江巨化技术中心有限公司 2023-12-19 CN disclosed
EP-4021441-A1 MEMBRANE-ACTIVE ANTI-BACTERIAL COMPOUNDS AND USES THEREOF Trustees of Dartmouth College (US) 2022-07-06 EP disclosed
EP-3927699-A1 MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN Nalo Therapeutics (US) 2021-12-29 EP disclosed
US-20210369710-A1 MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN NALO THERAPEUTICS (US) 2021-12-02 US disclosed
WO-2021042046-A1 MEMBRANE-ACTIVE ANTI-BACTERIAL COMPOUNDS AND USES THEREOF TRUSTEES OF DARTMOUTH COLLEGE (US) 2021-03-04 WO disclosed
US-10808246-B2 Oligonucleotide-ligand conjugates and process for their preparation ALNYLAM PHARMACEUTICALS, INC. (US) 2020-10-20 US disclosed
EP-3548469-B1 METHOD FOR THE MANUFACTURE OF EFAVIRENZ UNIV NELSON MANDELA METROPOLITAN (ZA) 2020-08-26 EP disclosed
EP-0679645-A1 Pharmacologically active CNS pyridmidin compounds THE WELLCOME FOUNDATION LIMITED (GB) 1995-11-02 EP disclosed
WO-1994029255-A1 AROMATIC ACETYLCHOLINESTERASE INHIBITORS MERRELL PHARMACEUTICALS INC. (US) 1994-12-22 WO disclosed
EP-0627400-A1 Aromatic acetylcholinesterase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1994-12-07 EP disclosed
EP-0459819-A2 Pharmacologically active CNS compound THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-04 EP disclosed
EP-0245230-A1 Substituted 2,6-substituted pyridine compounds Monsanto Company (US) 1987-11-11 EP disclosed
US-4097599-A PESTICIDES COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) 1978-06-27 US disclosed
US-4038405-A MITICIDES COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) 1977-07-26 US disclosed
US-3960736-A POLYSACCHARIDE THICKENING AGENT THE DOW CHEMICAL COMPANY (US) 1976-06-01 US disclosed